The Study
Sweeteners: erythritol, xylitol and cardiovascular risk—friend or foe?
This study is like a big summary of lots of different smaller studies, some in people, some in mice, and some in test tubes. It says people who have more erythritol or xylitol in their blood often have heart problems — but it doesn’t prove the sweeteners caused the problems. Maybe people with diabetes or obesity just have more of these substances naturally.
Analysis score
Maximum 5 for a narrative review.
Where the score came from
These sweeteners don't raise blood sugar much and may help you feel full, but some studies found people with higher levels in their blood had more heart problems — though it's not clear if the sweeteners caused it.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 52 / 100
Quality score
Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.
Key takeaways
Summary
Based on the study abstract and findings.
- 1The platelet effect is short-lived and may not matter in real life.
- 2The heart risk link likely reflects underlying metabolic problems, not the sweeteners themselves.
- 3But giving xylitol to very sick patients actually helps them control blood sugar better.
- 4People with higher blood levels of xylitol had a 57% higher risk of heart attacks or strokes.
- 5Eating 30g of either sweetener made platelets more sticky for 30 minutes.
- 6Giving xylitol through IV or dialysis lowered insulin needs by up to 50% in sick patients.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Cardiovascular Research
Year
2025
Authors
Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach, Arduino Arduini, Angelo D’Alessandro, Edoardo Gronda, Stefano Carugo, Mario Bonomini, Maurizio Gallieni, Valentina Masola, Anne Angelillo-Scherrer, Tommaso Prosdocimi, Gary D Lopaschuk
Related Content
Claims (5)
People with naturally higher levels of erythritol in their blood do not develop coronary artery disease, type 2 diabetes, or elevated fasting glucose because of those levels.
Consuming 30 grams of erythritol or xylitol causes platelets in healthy humans to respond more strongly to chemical signals like ADP and TRAP6 within 30 minutes, as measured in laboratory tests.
Eating erythritol and xylitol increases levels of the satiety hormones GLP-1, PYY, and CCK and leads to lower food intake in the short term.
Genetic evidence shows that higher blood levels of erythritol do not cause coronary artery disease, type 2 diabetes, or elevated fasting glucose, but are linked to slightly lower body mass index, indicating erythritol is a marker of metabolic state rather than a cause of disease.
Consuming 30 grams of erythritol or xylitol temporarily increases platelet aggregation when exposed to ADP and TRAP6 in healthy individuals.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.